Skip to Content

Dietrich Stephan

Dietrich Stephan

Dietrich Stephan

Chairman & CEO

NeuBase Therapeutics, Inc.


Dr. Stephan is Chairman and CEO of NeuBase Therapeutics (Nasdaq:NBSE) which is developing the next generation of gene silencing therapies to address genetic diseases including cancers. Stephan has been Chairman of several academic departments, founded 14 biotechnology companies and among other honors has been profiled twice on the front page of the Wall Street Journal for his contributions to society.